Novel Ophthalmic Implant Treats Glaucoma
|
By HospiMedica International staff writers Posted on 29 May 2018 |
|
Image: A novel implant helps glaucoma patients by improving aqueous humor outflow (Photo courtesy of iSTAR Medical).
An innovative micro-invasive glaucoma surgery (MIGS) device is highly effective for achieving significant intraocular pressure (IOP) reduction in glaucoma patients.
The iSTAR Medical (Wavre, Belgium) MINIject is an injected implant designed to reduce IOP in glaucoma patients by improving aqueous humor outflow from the anterior chamber to the suprachoroidal space. The MIGS implant conforms to the eye anatomy, providing sustained drainage efficacy over time due to bio-integration of surrounding tissues into the material. MINIject is based on proprietary sphere templated angiogenic regeneration (STAR) material, developed at the University of Washington (Seattle; USA).
STAR is a soft, flexible, medical-grade silicone with a micro-porous, multi-channel, geometry with pores that are precisely sized to match cellular dimensions, thus stimulating angiogenesis. The interstitial space between the granules provides pathways for larger vessels, which can sprout capillaries small enough to infiltrate the pore structure. The porous design also encourages a natural flow speed, which reduces the incidence of fibrosis and minimizes scarring by increasing implant durability and reducing foreign body response.
“iSTAR Medical is proud to bring this innovative solution to patients suffering with Glaucoma, a major cause of blindness globally,” said Michel Vanbrabrant, CEO of iSTAR Medical. “With our proprietary STAR material, and international support from leading experts, MINIject has the potential to become a best-in-class treatment for Glaucoma. Initial feedback from investigators is encouraging and we look forward to seeing the primary endpoint results next year.”
Glaucoma is an eye disease in which the optic nerve is damaged due to loss of retinal ganglion cells in a characteristic pattern, and is the second-leading cause of blindness after cataracts. It is normally associated with increased fluid pressure in the eye (aqueous humor). Glaucoma can be roughly divided into two main categories, "open-angle" and "closed-angle" glaucoma. Glaucoma has been called the "silent thief of sight" because the loss of vision often occurs gradually over a long period of time, and symptoms only occur when the disease is quite advanced.
Related Links:
iSTAR Medical
The iSTAR Medical (Wavre, Belgium) MINIject is an injected implant designed to reduce IOP in glaucoma patients by improving aqueous humor outflow from the anterior chamber to the suprachoroidal space. The MIGS implant conforms to the eye anatomy, providing sustained drainage efficacy over time due to bio-integration of surrounding tissues into the material. MINIject is based on proprietary sphere templated angiogenic regeneration (STAR) material, developed at the University of Washington (Seattle; USA).
STAR is a soft, flexible, medical-grade silicone with a micro-porous, multi-channel, geometry with pores that are precisely sized to match cellular dimensions, thus stimulating angiogenesis. The interstitial space between the granules provides pathways for larger vessels, which can sprout capillaries small enough to infiltrate the pore structure. The porous design also encourages a natural flow speed, which reduces the incidence of fibrosis and minimizes scarring by increasing implant durability and reducing foreign body response.
“iSTAR Medical is proud to bring this innovative solution to patients suffering with Glaucoma, a major cause of blindness globally,” said Michel Vanbrabrant, CEO of iSTAR Medical. “With our proprietary STAR material, and international support from leading experts, MINIject has the potential to become a best-in-class treatment for Glaucoma. Initial feedback from investigators is encouraging and we look forward to seeing the primary endpoint results next year.”
Glaucoma is an eye disease in which the optic nerve is damaged due to loss of retinal ganglion cells in a characteristic pattern, and is the second-leading cause of blindness after cataracts. It is normally associated with increased fluid pressure in the eye (aqueous humor). Glaucoma can be roughly divided into two main categories, "open-angle" and "closed-angle" glaucoma. Glaucoma has been called the "silent thief of sight" because the loss of vision often occurs gradually over a long period of time, and symptoms only occur when the disease is quite advanced.
Related Links:
iSTAR Medical
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Immobilization System
Cranial 4Pi Immobilization
New
Blood Gas Analyzer
i-Check200
Latest Surgical Techniques News
- Fiber-Form Bone Graft Expands Intraoperative Options for Spinal Fusion
- Ultrasound‑Aided Catheter Treatment Cuts Early Collapse in Pulmonary Embolism
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
Channels
Artificial Intelligence
view channel
AI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
Critical Care
view channel
Eye Imaging AI Identifies Elevated Cardiovascular Risk
Many adults at risk for atherosclerotic cardiovascular disease are not identified until they undergo formal primary care assessment. Delayed risk recognition can postpone initiation of statins and lifestyle... Read more
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
Voice-Driven AI System Enables Structured GI Procedure Documentation
Documentation during gastrointestinal (GI) procedures often competes with real-time clinical decision-making and imposes a significant cognitive burden on physicians. Manual data entry and post-procedure... Read more
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
